Beta-amyloid deposition and cognitive function in patients with major depressive disorder with different subtypes of mild cognitive impairment: 18F-florbetapir (AV-45/Amyvid) PET study
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Beta-amyloid deposition and cognitive function in patients with major depressive disorder with different subtypes of mild cognitive impairment: 18F-florbetapir (AV-45/Amyvid) PET study
Authors
Keywords
Major depressive disorder, Amyloid, <sup>18</sup>F-Florbetapir (AV-45/Amyvid), Alzheimer’s disease, Dementia, Mild cognitive impairment
Journal
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
Volume 43, Issue 6, Pages 1067-1076
Publisher
Springer Nature
Online
2016-01-07
DOI
10.1007/s00259-015-3291-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Lifetime History of Depression Predicts Increased Beta-Amyloid Accumulation in Patients with Mild Cognitive Impairment
- (2015) Jun Ku Chung et al. AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY
- Amyloid imaging with [18F]florbetapir in geriatric depression: early-onset versus late-onset
- (2014) Amane Tateno et al. INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY
- Late-life depression and risk of vascular dementia and Alzheimer's disease: systematic review and meta-analysis of community-based cohort studies
- (2013) Breno S. Diniz et al. BRITISH JOURNAL OF PSYCHIATRY
- Increased brain amyloid deposition in patients with a lifetime history of major depression: evidenced on 18F-florbetapir (AV-45/Amyvid) positron emission tomography
- (2013) Kuan-Yi Wu et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Perfusion-like template and standardized normalization-based brain image analysis using 18F-florbetapir (AV-45/Amyvid) PET
- (2013) Ing-Tsung Hsiao et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Using PET with 18F-AV-45 (florbetapir) to quantify brain amyloid load in a clinical environment
- (2012) V. Camus et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Amyloid deposition detected with florbetapir F 18 (18F-AV-45) is related to lower episodic memory performance in clinically normal older individuals
- (2012) Reisa A. Sperling et al. NEUROBIOLOGY OF AGING
- Short-term clinical outcomes for stages of NIA-AA preclinical Alzheimer disease
- (2012) D. S. Knopman et al. NEUROLOGY
- -Amyloid burden in healthy aging: Regional distribution and cognitive consequences
- (2012) K. M. Rodrigue et al. NEUROLOGY
- Independent contribution of temporal β-amyloid deposition to memory decline in the pre-dementia phase of Alzheimer’s disease
- (2011) Gaël Chételat et al. BRAIN
- Lack of association between prior depressive episodes and cerebral [11C]PiB binding
- (2011) Karine Madsen et al. NEUROBIOLOGY OF AGING
- PET amyloid imaging as a tool for early diagnosis and identifying patients at risk for progression to Alzheimer's disease
- (2011) Michael J Pontecorvo et al. Alzheimers Research & Therapy
- Subtypes of Mild Cognitive Impairment Among the Elderly With Major Depressive Disorder in Remission
- (2010) Yi-Chun Yeh et al. AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY
- GMP-compliant automated synthesis of [18F]AV-45 (Florbetapir F 18) for imaging β-amyloid plaques in human brain
- (2010) Cheng-Hsiang Yao et al. APPLIED RADIATION AND ISOTOPES
- In Vivo Imaging of Amyloid Deposition in Alzheimer Disease Using the Radioligand 18F-AV-45 (Flobetapir F 18)
- (2010) D. F. Wong et al. JOURNAL OF NUCLEAR MEDICINE
- Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging
- (2010) Christopher C. Rowe et al. NEUROBIOLOGY OF AGING
- Whole-body biodistribution and brain PET imaging with [18F]AV-45, a novel amyloid imaging agent — a pilot study
- (2010) Kun-Ju Lin et al. NUCLEAR MEDICINE AND BIOLOGY
- Patterns of Mild Cognitive Impairment After Treatment of Depression in the Elderly
- (2009) Rishi K. Bhalla et al. AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY
- Cognitive Decline and Brain Volume Loss as Signatures of Cerebral Amyloid-β Peptide Deposition Identified With Pittsburgh Compound B
- (2009) Martha Storandt et al. ARCHIVES OF NEUROLOGY
- Imaging Alzheimer Pathology in Late-Life Depression With PET and Pittsburgh Compound-B
- (2008) Meryl A. Butters et al. ALZHEIMER DISEASE & ASSOCIATED DISORDERS
- Episodic memory loss is related to hippocampal-mediated -amyloid deposition in elderly subjects
- (2008) E. C. Mormino et al. BRAIN
- Amyloid-β protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory
- (2008) Ganesh M Shankar et al. NATURE MEDICINE
- Plaque-bearing mice with reduced levels of oligomeric amyloid-β assemblies have intact memory function
- (2007) S. Lesné et al. NEUROSCIENCE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now